Agenda - Main Conference Day 2 | TIDES Asia: Oligonucleotide & Peptide Therapeutics

7:45am - 8:10am

Registration and Coffee

8:10am - 8:15am

Chairperson’s Remarks

Yogesh Sanghvi, PhD - President, Rasayan Inc.

8:15am - 8:45am

Morning Spotlight Presentation: Isolation and Drying of Peptides and 0ligonucleotides – Improved Production Capacities During Large Scale Manufacturing

Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems

Plenary Session

Showing 1 of 1 Streams

mRNA Advances Track

8:45am - 9:15am

Complete Chemical Synthesis of mRNA for Cancer Vaccine

Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University

9:15am - 9:45am

Developing the Next Generation RSV Vaccine

Dong Shen, MD, PhD - CEO, RNAimmune, Inc.

9:45am - 10:15am

RNA Therapy for Asthma

Thomas Langenickel, MD, PhD - Chief Medical Officer, Ethris GmbH

Showing 2 of 2 Streams

Networking Refreshment Break with Poster and Exhibit Viewing

TIDES Talks in the Exhibit Hall

10:15am - 10:55am

Networking Refreshment Break with Poster and Exhibit Viewing

10:20am - 10:35am

Initiating CMO Operations at Axolabs Berlin: From Discovery to Commercial Therapeutic Oligonucleotides

Thomas Rupp - Managing Director, Axolabs Berlin GmbH

Concurrent Conference Tracks

Showing 2 of 2 Streams

Oligonucleotide Track

Peptide Track

10:55am - 11:00am

Chairperson’s Remarks: Track 1

Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences

11:00am - 11:30am

CMC Strategies for the Characterization of Stereopure Platform Chemistry

Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences

11:30am - 12:00pm

Template-independent Enzymatic Synthesis of Natural and Fully Modified siRNA Oligonucleotides

Jonathan Rittichier, PhD - Chief Scientific Officer & Co-Founder, EnPlusOne BioSciences

12:00pm - 12:30pm

Empowering Oligonucleotide Therapeutics: From Raw Materials to Manufacturing, and Advanced Delivery Solutions

Sirat Sikka - Senior Scientist, Applications and Innovation, Thermo Fisher Scientific

10:55am - 11:00am

Chairperson’s Remarks: Track 2

El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group

11:00am - 11:30am

Refractive Index as an end to end PAT tool for monitoring solid phase synthesis of peptides and oligonucleotides

John Lopez, PhD - Associate Director Science & Technology, Novartis

11:30am - 12:00pm

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase

Dinesh Parmar - Associate Director Regulatory Affairs, PolyPeptide Group

12:00pm - 12:30pm

Statistical Design of Experiments in Peptide Process Development

Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group

12:30pm - 1:40pm

Networking Luncheon with Poster and Exhibit Viewing

Showing 2 of 2 Streams

Oligonucleotide Track

Peptide Track

1:40pm - 1:45pm

Chairperson’s Remarks: Track 1

Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences

1:45pm - 2:15pm

Drug Substance and Drug Product CMC Strategies for Start-Ups and Smaller Companies

Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC

2:15pm - 2:45pm

NMA Manufacturing Process Development

Carter Cooperman - Research Associate II, Ionis

2:45pm - 3:15pm

Advancements in Oligonucleotide Sequencing Capabilities

Collin Wetzel - Associate Principal Scientist, Analytical Development, Nitto Avecia

1:40pm - 1:45pm

Chairperson’s Remarks: Track 2

El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group

1:45pm - 2:15pm

Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide

Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.

2:15pm - 2:45pm

Overcoming Aggregation Challenges in Peptide Manufacturing: Technical Approach and Case Studies

El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group

2:45pm - 3:15pm

An Inline Monitoring Method Integrated Flow Chemistry for Peptide Synthesis and Manufacturing

Pengyu Xu, PhD - President and Representative Director, SynCrest Inc.

3:15pm - 3:45pm

Networking Refreshment Break with Poster and Exhibit Viewing

Showing 2 of 2 Streams

Oligonucleotide Track

Peptide Track

3:45pm - 4:15pm

Development of a Kilogram-Scale Manufacturing Route for Guadecitabine: A Dinucleotide DNA Methyltransferase Inhibitor

Yogesh Sanghvi, PhD - President, Rasayan Inc.

4:15pm - 4:45pm

Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents

Tsubasa Aoki, PhD - Researcher, Ajinomoto Co.

4:45pm - 5:15pm

Oligonucleotide Purification and CMC Strategies – Increasing Efficiencies/Overcoming Challenges

Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc

3:45pm - 4:15pm

Improving Robustness and Recovery in a GLP-1 Purification Process

Yvan Ruland, PhD - Technology Consultant Chromatography, Sartorius Stedim Singapore

4:15pm - 4:45pm

Liquid-phase Peptide Fragment Manufacturing Technologies and Workflows

Adrian Amador, PhD - Director of Process Chemistry, Cambrex

4:45pm - 5:15pm

A Breakthrough for “TIDEs” Researchers in CMC: Developing a State-of-the-Art Technology to Improve Upon Traditional Labor-Intensive Methods of Purification

Katsuhiko Miwa - CEO, ChromaJean

5:15pm - 6:15pm

Networking Cocktail Reception with Poster and Exhibit Viewing

Please join your fellow attendees in the exhibit hall for an evening of networking while enjoying beverages and appetizers.

6:15pm - 6:20pm

Close of Day Two

Main Conference Day 2Thursday, 27 February 2025

Get the Latest Event Updates